Last reviewed · How we verify

NCT05591508

Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus

Status unknown NA Last updated 26 January 2023
What this trial tests

NA trial testing Ketogenic Diet in Status Epilepticus in 50 participants. Status unknown.

Timeline
1 November 2022
Primary endpoint
30 November 2024
30 November 2024

Quick facts

Lead sponsorAll India Institute of Medical Sciences
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 November 2022
Primary completion30 November 2024
Estimated completion30 November 2024
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

All India Institute of Medical Sciences

Who can join

Adults 6 Months to 18, any sex, with Status Epilepticus or Ketogenic Dieting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ketogenic diet being started early in those with status epilepticus and frequent or abundant discharges in EEG in comparison to just standard therapy is being evaluated here for efficacy and adverse effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ketogenic Diet

Trials testing the same drug.

Other recruiting trials for Status Epilepticus

Currently open trials in the same condition.

Other All India Institute of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing